Miao Miao, Chen Zhikui. Epicardial Versus Circulating Adiponectin: An Unresolved Distinction in Liraglutide‘s Anti-Arrhythmic Mechanism. // Cardiovascular Drugs and Therapy. – 2026. – DOI: 10.1007/s10557-026-07977-1. – URL: https://doi.org/10.1007/s10557-026-07977-1
Miao Miao & Chen Zhikui (2026). Epicardial Versus Circulating Adiponectin: An Unresolved Distinction in Liraglutide‘s Anti-Arrhythmic Mechanism. Cardiovascular Drugs and Therapy. https://doi.org/10.1007/s10557-026-07977-1
Miao Miao and Chen Zhikui. “Epicardial Versus Circulating Adiponectin: An Unresolved Distinction in Liraglutide‘s Anti-Arrhythmic Mechanism.” Cardiovascular Drugs and Therapy, 2026. doi:10.1007/s10557-026-07977-1.
@article{Miao2026,
title = {Epicardial Versus Circulating Adiponectin: An Unresolved Distinction in Liraglutide‘s Anti-Arrhythmic Mechanism},
author = {Miao, Miao and Zhikui, Chen},
journal = {Cardiovascular Drugs and Therapy},
year = {2026},
doi = {10.1007/s10557-026-07977-1},
url = {https://doi.org/10.1007/s10557-026-07977-1}
}